Prevention & Chronic Conditions


Cardiovascular disease (CVD) is a significant and ever-growing problem in the UK, accounting for nearly one-third of all deaths and leading to significant morbidity. Globally CVD accounts for 31% of mortality, mainly from heart disease and cerebrovascular accident.

The burden of CVD can be ameliorated by careful risk modification and primary prevention is an important priority for all developers of health policy. Strong consensus exists between international guidelines regarding the necessity of smoking cessation, weight optimisation and exercise, although guidelines have slightly different approaches to hypertension and vary considerably regarding their approach to optimal lipid profile, which remains a contentious issue.

Related Articles


COVID-19 Pandemic and Cardiovascular Disease

Aniket S Rali, Andrew J Sauer,


Citation: US Cardiology Review 2020;14:e01.

Major Cardiovascular Advances: Highlights from the 2019 American College…

Hisham A Badreldin, Khalid bin Saleh, Majed Al-Yami,


Citation: US Cardiology Review 2019;13(2):105–9.

Baroreflex Activation Therapy for Resistant Hypertension and Heart Failure

Deepak L Bhatt, Anna Meta Dyrvig Kristensen, Manan Pareek,


Citation: US Cardiology Review 2019;13(2):83–7.

Early Management of Hypertension

Deborah L Nadler, Athena Poppas,


Citation: US Cardiology Review 2019;13(1):58–60